Cure My Disease

Don't miss your cure!

 Log in / Sign up

A gentle nerve zap may calm an overactive bladder

NCT ID NCT07796958

Symptom relief Sponsor: University Hospital Ostrava Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This trial tests a treatment called peroneal electric transcutaneous neuromodulation, or peroneal eTNM, for people with overactive bladder syndrome. The procedure uses mild electrical pulses to stimulate the peroneal nerve near the ankle, which may help reduce the sudden, strong urge to urinate. Researchers will enroll 300 adults who have been prescribed this treatment in everyday clinical practice. They will measure how much symptoms improve and how satisfied patients feel using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Peroneal electric transcutaneous neuromodulation (peroneal eTNM), a procedure that stimulates the peroneal nerve to influence overactive bladder symptoms
What this could lead to
If it works, this could offer a non-drug, non-surgical option for people with overactive bladder to reduce urgent, frequent urination and improve daily comfort.
What could go wrong
This is a real-world study, not a controlled experiment, so results may be influenced by other factors. The treatment may not work for everyone, and nerve stimulation can cause discomfort or skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with OAB.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects (male and female) aged 18 years and over * Subjects diagnosed with OAB or mixed urinary incontinence with a predominant urge component who were indicated for treatment with peroneal eTNM * Subjects who consent to the processing of anonymized demographic data and anonymized treatment data with peroneal eTNM Exclusion Criteria: * Subjects with contraindications to treatment with peroneal eTNM * Subjects who express their disagreement with the processing of anonymised demographic data and anonymised treatment data with peroneal eTNM

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overactive bladder syndrome are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

overactive bladder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overactive bladder syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital Ostrava

    Ostrava, Moravian-Silesian Region, 70852, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.